REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2021 Conference
ROCKVILLE, Md., Feb. 5, 2021 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced that two oral presentations will be presented at the Angiogenesis, Exudation, and Degeneration 2021 conference taking place virtually from February 12 to 13, 2021. The presentations will be as…
Comments Off on REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2021 Conference